Dr. Mary Sano is professor of psychiatry and the director of the Alzheimer's disease research at Mount Sinai School of Medicine. She is also the director of research and development at the Bronx Veterans Administration Hospital. Currently she is the director of a national multi-center study known as CLASP (Cholesterol Lowering in Alzheimer's Disease to Slow Progression). Dr. Sano is a neuropsychologist by training and has been involved in designing and conducting clinical trials for Alzheimer's disease, Parkinson's disease, and mild cognitive impairment of aging. In 1989 she received the Florence and Herbert Irving Clinical Research Career Award to develop methodologies for the assessment of therapeutic agents in Alzheimer's disease. She directed the first ADCS multicenter trial of vitamin E and Selegiline, treatments which delayed the clinical progression of Alzheimer's disease and in 1998 she received the Veris Award for this study. In this study minority participation was more than double that of any other clinical trial for this disease. Her research interests are in clinical trial design and the impact of pharmacological treatments on the functional abilities of individuals with cognitive impairment.

Frontiers of BrainHealth is a hybrid speaker series. By registering for the season, you get a link to virtual talks as well as recordings. If you are interested in attending any talks in person, you can confirm in-person attendance when we send a reminder email a few days prior to each talk. Register for Season